por
Beleigoli, Alline,
Nicholls, Stephen J,
Brown, Alex,
Chew, Derek P,
Beltrame, John,
Maeder, Anthony,
Maher, Carol,
Versace, Vincent L,
Hendriks, Jeroen M,
Tideman, Philip,
Kaambwa, Billingsley,
Zeitz, Christopher,
Prichard, Ivanka J,
Tavella, Rosanna,
Tirimacco, Rosy,
Keech, Wendy,
Astley, Carolyn,
Govin, Kay,
Nesbitt, Katie,
Du, Huiyun,
Champion, Stephanie,
Pinero de Plaza, Maria Alejandra,
Lynch, Imelda,
Poulsen, Vanessa,
Ludlow, Marie,
Wanguhu, Ken,
Meyer, Hendrika,
Krollig, Ali,
Gebremichael, Lemlem,
Green, Chloe,
Clark, Robyn A
Publicado 2022
“…To evaluate 12-month CR attendance/completion (primary outcome), clinical and
cost-effectiveness (secondary outcomes) between patients exposed (n=1223) and not exposed (n=3669) to CHAP, we will apply a multidesign approach that encompasses a prospective cohort study, a pre-
post study and a comprehensive economic evaluation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto